n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with ro 25-6981 in 1 studies
| Studies (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Trials (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Recent Studies (post-2010) (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Studies (ro 25-6981) | Trials (ro 25-6981) | Recent Studies (post-2010) (ro 25-6981) |
|---|---|---|---|---|---|
| 98 | 0 | 29 | 221 | 0 | 137 |
| Protein | Taxonomy | n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride (IC50) | ro 25-6981 (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | 0.006 | |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | 0.006 | |
| Prolyl endopeptidase | Sus scrofa (pig) | 0.006 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.006 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.0311 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.058 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.0426 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.058 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.0315 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.006 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.024 | |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | 0.006 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.058 | |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | 0.006 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.058 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.058 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Hong, J; Sha, S; Wang, C; Yin, J; Zhou, L | 1 |
1 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and ro 25-6981
| Article | Year |
|---|---|
Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anisoles; Astrocytes; Cell Death; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Morpholines; Neuroprotective Agents; Parkinson Disease, Secondary; Pars Compacta; Phenols; Phosphorylation; Piperidines; Propylamines; Psychomotor Performance; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Sigma-1 Receptor; Signal Transduction; Vesicular Monoamine Transport Proteins | 2015 |